Valuation: UCB

Market Cap 47.63B 54.27B 44.35B 40.79B 76.47B 5,185B 77.78B 526B 206B 2,571B 204B 199B 8,884B P/E 2026 *
26.8x
P/E 2027 * 21.3x
Enterprise Value 47.39B 54B 44.13B 40.59B 76.08B 5,159B 77.39B 524B 205B 2,558B 203B 198B 8,839B EV / Sales 2026 *
5.55x
EV / Sales 2027 * 4.7x
Free-Float
61.59%
Yield 2026 *
0.59%
Yield 2027 * 0.6%
1 day+0.12%
1 week+2.96%
Current month-4.39%
1 month-4.93%
3 months+10.74%
6 months-0.99%
Current year+4.99%
1 week 238.9
Extreme 238.9
251.3
1 month 230.7
Extreme 230.7
268.3
Current year 223
Extreme 223
289.5
1 year 181.15
Extreme 181.15
289.5
3 years 65.4
Extreme 65.4
289.5
5 years 65.4
Extreme 65.4
289.5
10 years 54.84
Extreme 54.84
289.5
Manager TitleAgeSince
Chief Executive Officer 67 2014-12-31
Director of Finance/CFO 59 2020-06-30
Chief Tech/Sci/R&D Officer 59 2024-04-30
Director TitleAgeSince
Director/Board Member 55 2011-12-31
Director/Board Member 67 2014-12-31
Director/Board Member 56 2014-04-23
Date Insider Type Main position Quantity % Market Cap.
1/15/26 Buy

Director

500 0.0003%
1/15/26 Fiscal year

Executive/Senior Manager

3,000 0.0015%
1/15/26 Fiscal year

Executive/Senior Manager

3,000 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
+0.08%+2.96%+35.37%+211.10% 54.27B
+4.20%+2.96%+24.44%-6.82% 70.73B
+0.26%+54.90%+54.90%+54.90% 49.28B
+7.15%+8.59%-52.92%-52.31% 39.94B
+2.73%+1.21%+59.04%-22.48% 30.36B
+9.30%+10.68%+85.19%+105.94% 25.96B
+0.31%-6.46%+64.57%-52.97% 22.14B
-0.11%-2.66%-10.16%+159.54% 19.96B
+0.54%+1.38%+66.17%+127.96% 16.72B
+1.70%+3.76%+85.05%+148.55% 16.77B
Average +2.62%+2.40%+41.17%+67.34% 34.61B
Weighted average by Cap. +2.80%+3.22%+34.68%+58.65%

Financials

2026 *2027 *
Net sales 8.54B 9.73B 7.96B 7.32B 13.72B 930B 13.95B 94.38B 36.94B 461B 36.55B 35.76B 1,594B 9.64B 10.99B 8.98B 8.26B 15.48B 1,050B 15.75B 107B 41.7B 521B 41.25B 40.36B 1,799B
Net income 1.77B 2.02B 1.65B 1.52B 2.84B 193B 2.89B 19.55B 7.65B 95.56B 7.57B 7.41B 330B 2.28B 2.59B 2.12B 1.95B 3.66B 248B 3.72B 25.16B 9.85B 123B 9.74B 9.53B 425B
Net Debt -242M -276M -226M -207M -389M -26.37B -396M -2.68B -1.05B -13.08B -1.04B -1.01B -45.18B -2.32B -2.65B -2.16B -1.99B -3.73B -253B -3.79B -25.67B -10.05B -125B -9.94B -9.72B -433B
Logo UCB
UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.
Employees
9,765
Date Price Change Volume
26-07-29 250.30 +0.04% 18,679
26-07-28 €250.20 +1.79% 227,096
26-07-27 €245.80 -0.08% 136,709
26-07-24 €246.00 +1.23% 149,516
26-07-23 €243.00 -0.12% 205,984
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
250.20EUR
Average target price
287.95EUR
Spread / Average Target
+15.09%

Quarterly revenue - Rate of surprise